Celum CL - Search Results

1

Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression.

Moore JR, Donnell DJ, Boily MC, Mitchell KM, Delany-Moretlwe S, Bekker LG, Mgodi NM, El-Sadr W, Cohen MS, Celum CL, Dimitrov D. Moore JR, et al. Among authors: celum cl. J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):423-429. doi: 10.1097/QAI.0000000000002481. J Acquir Immune Defic Syndr. 2020. PMID: 33136739 Free PMC article.

2

Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.

Celum CL, Buchbinder SP, Donnell D, Douglas JM Jr, Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW. Celum CL, et al. J Infect Dis. 2001 Jan 1;183(1):23-35. doi: 10.1086/317658. Epub 2000 Dec 8. J Infect Dis. 2001. PMID: 11106536

3

Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.

Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C, Buchbinder S, Koblin B, Seage GR 3rd; HIV Network for Prevention Trials Vaccine Preparedness Protocol Team. Marmor M, et al. J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):472-81. doi: 10.1097/00126334-200108150-00009. J Acquir Immune Defic Syndr. 2001. PMID: 11511825

4

Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men.

Spielberg F, Branson BM, Goldbaum GM, Lockhart D, Kurth A, Celum CL, Rossini A, Critchlow CW, Wood RW. Spielberg F, et al. Among authors: celum cl. J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):318-27. doi: 10.1097/00126334-200303010-00012. J Acquir Immune Defic Syndr. 2003. PMID: 12626893

5

Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel: 3 randomized trials in healthy low-risk men and HIV-positive men.

Tabet SR, Callahan MM, Mauck CK, Gai F, Coletti AS, Profy AT, Moench TR, Soto-Torres LE, Poindexter III AN, Frezieres RG, Walsh TL, Kelly CW, Richardson BA, Van Damme L, Celum CL. Tabet SR, et al. Among authors: celum cl. J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):476-83. doi: 10.1097/00126334-200308010-00008. J Acquir Immune Defic Syndr. 2003. PMID: 12869836 Clinical Trial.

6

The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics.

Corey L, Wald A, Celum CL, Quinn TC. Corey L, et al. Among authors: celum cl. J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):435-45. doi: 10.1097/00126334-200404150-00001. J Acquir Immune Defic Syndr. 2004. PMID: 15021308 Review.

7

Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.

Celum CL, Robinson NJ, Cohen MS. Celum CL, et al. J Infect Dis. 2005 Feb 1;191 Suppl 1:S107-14. doi: 10.1086/425272. J Infect Dis. 2005. PMID: 15627220 Review.

8

HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial.

Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M, Marmor M, Novak RM, Mayer K, Creticos C, Orozco-Cronin P, Popovic V, Mastro TD; VISION/VAX004 Study Team. Bartholow BN, et al. J Acquir Immune Defic Syndr. 2005 May 1;39(1):90-101. doi: 10.1097/01.qai.0000143600.41363.78. J Acquir Immune Defic Syndr. 2005. PMID: 15851919 Clinical Trial.

9

Linking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance.

Lama JR, Sanchez J, Suarez L, Caballero P, Laguna A, Sanchez JL, Whittington WL, Celum C, Grant RM; Peruvian HIV Sentinel Surveillance Working Group. Lama JR, et al. J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):501-5. doi: 10.1097/01.qai.0000221677.29693.dd. J Acquir Immune Defic Syndr. 2006. PMID: 16773026

10

Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION.

Whittington WL, Morris M, Buchbinder SP, McKirnan DJ, Mayer KH, Para MF, Bartholow BN, Celum CL. Whittington WL, et al. Among authors: celum cl. J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):234-8. doi: 10.1097/01.qai.0000230296.06829.14. J Acquir Immune Defic Syndr. 2006. PMID: 16951646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters